<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="/resources/spdi-openaccess-jats.xsl"?>
<!DOCTYPE response [
	
<!ENTITY % article SYSTEM "http://jats.nlm.nih.gov/archiving/1.2/JATS-archivearticle1.dtd">
<!ENTITY % book-part-wrapper SYSTEM "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
	]><response><apiMessage>This XML was provided by Springer Nature</apiMessage><query>doi:10.1186/s12879-019-4152-7</query><apiKey>6b19ee21fe6a243741a528650f7c8997</apiKey><result><total>1</total><start>1</start><pageLength>1</pageLength><recordsDisplayed>1</recordsDisplayed></result><records><article dtd-version="1.2" article-type="research-article" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><?properties open_access?><front><journal-meta><journal-id journal-id-type="publisher-id">12879</journal-id><journal-title-group><journal-title>BMC Infectious Diseases</journal-title><abbrev-journal-title abbrev-type="publisher">BMC Infect Dis</abbrev-journal-title></journal-title-group><issn pub-type="epub">1471-2334</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">s12879-019-4152-7</article-id><article-id pub-id-type="manuscript">4152</article-id><article-id pub-id-type="doi">10.1186/s12879-019-4152-7</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="article-collection" specific-use="SubjectSection"><subject>Tuberculosis and other mycobacterial diseases</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Frequency of the <italic>Mycobacterium tuberculosis</italic> RD<sup>Rio</sup> genotype and its association with multidrug-resistant tuberculosis</article-title></title-group><contrib-group><contrib contrib-type="author" id="Au1"><name><surname>de Almeida</surname><given-names>Isabela Neves</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au2"><name><surname>Vasconcellos</surname><given-names>Sidra Ezidio Gonçalves</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" id="Au3"><name><surname>de Assis Figueredo</surname><given-names>Lida Jouca</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au4"><name><surname>Dantas</surname><given-names>Nayanne Gama Teixeira</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au5"><name><surname>Augusto</surname><given-names>Cláudio José</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" id="Au6"><name><surname>Hadaad</surname><given-names>João Paulo Amaral</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" id="Au7"><name><surname>Suffys</surname><given-names>Philip Noel</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" id="Au8"><name><surname>da Silva Carvalho</surname><given-names>Wânia</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" corresp="yes" id="Au9"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7245-4472</contrib-id><name><surname>de Miranda</surname><given-names>Silvana Spíndola</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="corresp" rid="IDs1287901941527_cor9">j</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2181 4888</institution-id><institution-id institution-id-type="GRID">grid.8430.f</institution-id><institution content-type="org-division">Laboratório de Pesquisa em Micobactérias, Faculdade de Medicina</institution><institution content-type="org-name">Universidade Federal de Minas Gerais (UFMG)</institution></institution-wrap><addr-line content-type="city">Belo Horizonte</addr-line><addr-line content-type="state">MG</addr-line><country country="BR">Brazil</country></aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0723 0931</institution-id><institution-id institution-id-type="GRID">grid.418068.3</institution-id><institution content-type="org-division">Laboratório de Biologia Molecular Aplicada a Micobactérias</institution><institution content-type="org-name">Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (FIOCRUZ)</institution></institution-wrap><addr-line content-type="city">Rio de Janeiro</addr-line><addr-line content-type="state">RJ</addr-line><country country="BR">Brazil</country></aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9688 4664</institution-id><institution-id institution-id-type="GRID">grid.472872.c</institution-id><institution content-type="org-name">Fundação Ezequiel Dias (FUNED)</institution></institution-wrap><addr-line content-type="city">Belo Horizonte</addr-line><addr-line content-type="state">MG</addr-line><country country="BR">Brazil</country></aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2181 4888</institution-id><institution-id institution-id-type="GRID">grid.8430.f</institution-id><institution content-type="org-name">Escola de Veterinária (UFMG)</institution></institution-wrap><addr-line content-type="city">Belo Horizonte</addr-line><addr-line content-type="state">MG</addr-line><country country="BR">Brazil</country></aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2181 4888</institution-id><institution-id institution-id-type="GRID">grid.8430.f</institution-id><institution content-type="org-name">Faculdade de Farmácia (UFMG)</institution></institution-wrap><addr-line content-type="city">Belo Horizonte</addr-line><addr-line content-type="state">MG</addr-line><country country="BR">Brazil</country></aff></contrib-group><author-notes><corresp id="IDs1287901941527_cor9"><label>j</label><email>silvanaspindola@gmail.com</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>25</day><month>6</month><year>2019</year></pub-date><pub-date date-type="collection" publication-format="electronic"><month>12</month><year>2019</year></pub-date><volume>19</volume><issue seq="556">1</issue><elocation-id>556</elocation-id><history><date date-type="registration"><day>31</day><month>5</month><year>2019</year></date><date date-type="received"><day>28</day><month>2</month><year>2019</year></date><date date-type="accepted"><day>31</day><month>5</month><year>2019</year></date><date date-type="online"><day>25</day><month>6</month><year>2019</year></date></history><permissions><copyright-statement>© The Author(s). 2019</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link xlink:href="http://creativecommons.org/licenses/by/4.0/" ext-link-type="url">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link xlink:href="http://creativecommons.org/publicdomain/zero/1.0/" ext-link-type="url">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1" xml:lang="en"><title>Abstract</title><sec id="ASec1"><title>Background</title><p id="Par1">In recent decades, <italic>Mycobacterium tuberculosis</italic> with the RD<sup>Rio</sup> genotype, frequently isolated from tuberculosis patients in Rio de Janeiro, has become part of the Latin American – Mediterranean (LAM) family and has been associated with multidrug-resistant tuberculosis (MDR-TB). The aim of this study was to investigate the frequency of <italic>M. tuberculosis</italic> RD<sup>Rio</sup> in the state of Minas Gerais, Brazil, and its relationship with MDR-TB.</p></sec><sec id="ASec2"><title>Methods</title><p id="Par2">For convenience, 172 susceptible and 63 MDR <italic>M. tuberculosis</italic> isolates were taken from pulmonary samples from patients diagnosed between January 2007 and December 2011. The DNA extracted from these isolates was analyzed by spoligotyping, PCR-RFLP to characterize <italic>fbpC</italic><sup><italic>103</italic></sup><italic>/</italic>Ag85C103, multiplex PCR to detect RD<sup>Rio</sup> and RD174, and MIRU-VNTR <italic>24 loci</italic>.</p></sec><sec id="ASec3"><title>Results</title><p id="Par3">Among the 235 isolates, the RD<sup>Rio</sup> pattern was identified in 122 (51.9%) isolates (IC 0.45–0.58), with 100 (42.5%) wild-type and 13 (5.5%) mixed pattern isolates, whereas RD174 was identified in 93 of the 122 RD<sup>Rio</sup> positive samples (76.3%). The LAM family and the LAM9 lineage were the most frequently identified among the isolates in this study. Among the 63 MDR isolates<italic>,</italic> 41 (65.1%) were RD<sup>Rio</sup> and 28 (44.4%) RD174.</p></sec><sec id="ASec4"><title>Conclusion</title><p id="Par4">The association of both deletions with MDR proved to be statistically significant, corroborating the few reports that have associated RD<sup>Rio</sup> with MDR.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Tuberculosis</kwd><kwd><italic>Mycobacterium tuberculosis</italic></kwd><kwd>Multidrug-resistant tuberculosis</kwd><kwd>Genotype</kwd><kwd>Single nucleotide polymorphisms</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution>FAPEMIG</institution><institution-id institution-id-type="doi" vocab="open-funder-registry">http://dx.doi.org/10.13039/501100004901</institution-id></institution-wrap></funding-source><award-id award-type="FundRef grant">APQ 03266-13/APQ 00094-12</award-id></award-group><award-group><funding-source><institution-wrap><institution>National Research Council CNPq</institution><institution-id institution-id-type="doi" vocab="open-funder-registry">http://dx.doi.org/10.13039/501100003593</institution-id></institution-wrap></funding-source><award-id award-type="FundRef grant">CNPq 446796/2014 and 310174/2017-7</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>publisher-imprint-name</meta-name><meta-value>BioMed Central</meta-value></custom-meta><custom-meta><meta-name>volume-issue-count</meta-name><meta-value>1</meta-value></custom-meta><custom-meta><meta-name>issue-article-count</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-pricelist-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-holder</meta-name><meta-value>The Author(s)</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-contains-esm</meta-name><meta-value>Yes</meta-value></custom-meta><custom-meta><meta-name>article-numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-month</meta-name><meta-value>5</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-day</meta-name><meta-value>31</meta-value></custom-meta><custom-meta><meta-name>article-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>volume-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>journal-product</meta-name><meta-value>ArchiveJournal</meta-value></custom-meta><custom-meta><meta-name>numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-grants-type</meta-name><meta-value>OpenChoice</meta-value></custom-meta><custom-meta><meta-name>metadata-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>abstract-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodypdf-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodyhtml-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bibliography-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>esm-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>online-first</meta-name><meta-value>false</meta-value></custom-meta><custom-meta><meta-name>pdf-file-reference</meta-name><meta-value>BodyRef/PDF/12879_2019_Article_4152.pdf</meta-value></custom-meta><custom-meta><meta-name>pdf-type</meta-name><meta-value>Typeset</meta-value></custom-meta><custom-meta><meta-name>target-type</meta-name><meta-value>OnlinePDF</meta-value></custom-meta><custom-meta><meta-name>issue-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>article-type</meta-name><meta-value>OriginalPaper</meta-value></custom-meta><custom-meta><meta-name>journal-subject-primary</meta-name><meta-value>Medicine &amp; Public Health</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Infectious Diseases</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Parasitology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Medical Microbiology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Tropical Medicine</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Internal Medicine</meta-value></custom-meta><custom-meta><meta-name>journal-subject-collection</meta-name><meta-value>Medicine</meta-value></custom-meta><custom-meta><meta-name>open-access</meta-name><meta-value>true</meta-value></custom-meta></custom-meta-group></article-meta><notes notes-type="ESMHint"><title>Electronic supplementary material</title><p>The online version of this article (<ext-link xlink:href="https://doi.org/10.1186/s12879-019-4152-7" ext-link-type="doi">https://doi.org/10.1186/s12879-019-4152-7</ext-link>) contains supplementary material, which is available to authorized users.</p></notes></front><body><sec id="Sec1"><title>Background</title><p id="Par14">In 2017, 10 million new cases of tuberculosis (TB) were reported worldwide, with 558,000 new cases of rifampicin-resistant tuberculosis (RR-TB). Among RR-TB cases, an estimated 82% had multidrug-resistant TB (MDR-TB), and in Brazil in the same year, there were 2000 cases of MDR/RR-TB among pulmonary TB cases [<xref ref-type="bibr" rid="CR1">1</xref>]. <italic>Mycobacterium tuberculosis</italic> (<italic>M. tuberculosis</italic>) is a human pathogen that undergoes clonal evolution, resulting in divergent lineages associated with specific geographic regions, and possibly with different human ethnic populations [<xref ref-type="bibr" rid="CR2">2</xref>]. These varied lineages present with biological differences regarding transmissibility [<xref ref-type="bibr" rid="CR3">3</xref>].</p><p id="Par15">Molecular analyses based on specific genetic markers enable the rapid identification of different species and sublineages, an important tool for studying the evolution and transmission of <italic>M. tuberculosis</italic> [<xref ref-type="bibr" rid="CR4">4</xref>]. The marker used to characterize the Latin American - Mediterranean (LAM) family is the single nucleotide polymorphism (SNP) <italic>fbpC</italic><sup><italic>103</italic></sup><italic>/</italic>Ag85C103, which is considered important for identification due to its high specificity. In addition, regions of difference such as RD<sup>Rio</sup> and RD174 are also lineage specific, and the latter has been associated with higher levels of transmissibility [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par16">The LAM family accounts for approximately 15% of the global burden of TB, and is present in 46% of the isolates that have been analyzed through genotyping in Brazil [<xref ref-type="bibr" rid="CR4">4</xref>]. The LAM9 lineage in particular represents 10.2% of the isolates of <italic>M. tuberculosis</italic> on the American continent [<xref ref-type="bibr" rid="CR5">5</xref>]. In 2007, Lazzarini et al. [<xref ref-type="bibr" rid="CR6">6</xref>] described a genotype of <italic>M. tuberculosis</italic> called RD<sup>Rio</sup>, which is exclusively found as a sublineage derived from the LAM family [<xref ref-type="bibr" rid="CR6">6</xref>]. It is believed that this genotype originated from a progenitor LAM9 and gave rise to the sublineages LAM1, LAM2, LAM4, and LAM5, as documented by the successive loss of spacers in spoligotype patterns [<xref ref-type="bibr" rid="CR6">6</xref>–<xref ref-type="bibr" rid="CR8">8</xref>].</p><p id="Par17">The <italic>M. tuberculosis</italic> RD<sup>Rio</sup> genotype contains a 26.3 kb deletion that causes the loss and modification of 10 genes, including two PPE (<italic>Proline-glutamic Acid Proteins</italic>) genes which encode specific proteins important for immunomodulation [<xref ref-type="bibr" rid="CR5">5</xref>]. This sublineage has been isolated in several places in Brazil and other countries, and has been associated with higher levels of transmission, such as that found in MDR-TB [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR7">7</xref>].</p><p id="Par18">Another important molecular technique that allows for the phylogenetic study of the <italic>M. tuberculosis</italic> complex is the Variable Number Tandem Repeat – Mycobaterial Interspersed Repetitive Unit (MIRU-VNTR 24 loci) based genotyping tool. This, together with spoligotyping, resulted in the construction of large genotypic databases that allowed for the phylogenetic analysis and study on the global distribution of <italic>M. tuberculosis</italic> [<xref ref-type="bibr" rid="CR9">9</xref>]. Genotyping by means of MIRU-VNTR 24 loci also enables the study of the epidemiologically significant clonal diversity of <italic>M. tuberculosis</italic> strains, which is useful for exploring internal phylogenetic ramifications [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR11">11</xref>]. There are some studies that describe the frequency of <italic>M. tuberculosis</italic> RD<sup>Rio</sup> in certain populations, but data evaluating the significance of this relationship by means of specific statistical tests on the co-occurrence of this genotype with MDR-TB are scarce, and no such data is available for the state of Minas Gerais [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. In this context, the aim of this study was to evaluate the frequency of <italic>M. tuberculosis</italic> RD<sup>Rio</sup> isolation in this region of Brazil, and its relationship with MDR-TB and other genetic markers affecting the drug susceptibility profile.</p></sec><sec id="Sec2" sec-type="methods"><title>Methods</title><sec id="Sec3"><title>Study design</title><p id="Par19">For convenience, 172 susceptible and 63 MDR-TB (strains defined as drug resistant to at least isoniazid and rifampin) <italic>M. tuberculosis</italic> isolates were collected. Isolates with single-drug resistance were not included.</p><p id="Par20">The isolates were obtained from pulmonary samples (sputum and bronchoalveolar lavage) from patients diagnosed between January 2007 and December 2011, in Minas Gerais.</p><p id="Par21">In this state, the mean MDR-TB rate was 0.2% among clinical TB cases between 2002 and 2009 [<xref ref-type="bibr" rid="CR13">13</xref>], while after this period MDR-TB detection rates increased due to the expansion of culture and the susceptibility testing. In the present study, the identification of <italic>M. tuberculosis</italic> was performed by phenotypic testing [<xref ref-type="bibr" rid="CR14">14</xref>], while drug susceptibility testing was conducted using the BACTEC™ MGIT™ 960 system (Becton Dickinson®), according to manufacturer’s instructions [<xref ref-type="bibr" rid="CR15">15</xref>], in the Main Public Health Laboratory of the state of Minas Gerais located in the Octavio Magalhães Institute of the Ezequiel Dias Foundation in Belo Horizonte. All 235 clinical isolates were analyzed by means of the molecular tests described below, the results of which are included in the statistical analyses.</p></sec><sec id="Sec4"><title>DNA extraction</title><p id="Par22">The genomic DNA of <italic>M. tuberculosis</italic> was extracted from subcultured colonies in Lowenstein-Jensen solid medium using 10% Cetyltrimethylammonium Bromide (CTAB) as described by Dantas et al. [<xref ref-type="bibr" rid="CR16">16</xref>] in 2015. The extracted DNA was used for the techniques described below. The experiments were performed in duplicate, with the exception of spoligotyping and MIRU-VNTR 24 loci.</p></sec><sec id="Sec5"><title>Multiplex PCR - RD<sup>Rio</sup></title><p id="Par23">The detection of the RD<sup>Rio</sup> pattern was performed by multiplex PCR, using the following set of primers: BridgeRD<sup>Rio</sup>F, BridgeRD<sup>Rio</sup>R, IS1561F, and IS161R, and was confirmed by the presence or absence of 1175 and/or 530 bp fragments. The RD<sup>Rio</sup> pattern presents a 1175 bp fragment, while the wild-type (WT) produces a 530 bp fragment [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>].</p></sec><sec id="Sec6"><title>Multiplex PCR - RD174</title><p id="Par24">To perform amplification, we used the PCR protocol describe by Gibson et al. [<xref ref-type="bibr" rid="CR4">4</xref>] in 2008, and adapted by Vasconcelos et al. [<xref ref-type="bibr" rid="CR7">7</xref>] in 2014. Briefly, we used a primer for each of the following: RD174 F, RD174Fi, and RD174 R. The isolates showing an intact RD174 region (WT) produced 300 bp fragments, while the RD174 deletion presented as 500 bp fragments [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR7">7</xref>].</p></sec><sec id="Sec7"><title>Spoligotyping</title><p id="Par25">Spoligotyping was performed using the Beamedex® microsphere technique in a Luminex-Bioplex-BioRad 200® system, as developed in the “Institut de Genétique et Microbiologi e Université Paris-Sud”, and following the protocol described by Zhang et al. (2010) [<xref ref-type="bibr" rid="CR17">17</xref>].</p></sec><sec id="Sec8"><title>PCR-RFLP fbpC<sup>103</sup>/Ag85C103</title><p id="Par26">The SNP <italic>fbp</italic>C<sup>103</sup>,or Ag85C103, was described as a specific marker for the LAM lineage by Gibson et al. [<xref ref-type="bibr" rid="CR4">4</xref>] in 2008. The PCR protocol used in this study was adapted as described by Vasconcelos et al. [<xref ref-type="bibr" rid="CR7">7</xref>] in 2014. To perform the amplification, we used this set of primers: fbpC103 F and <italic>fbpC</italic><sup><italic>103</italic></sup> R. The amplified products (519 bp) were analyzed on 2% agarose gel in 1× TBE. After this step, the enzymatic digestion was performed by restriction enzyme <italic>Mn</italic>II (New England BioLabs Inc. USA). The <italic>Mn</italic>II enzyme produces three restriction fragments in the amplified product: 365 bp, 96 bp, and 48 bp. The presence of SNP (G309A) (LAM) results in the loss of one of the three restriction sites [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR7">7</xref>].</p></sec><sec id="Sec9"><title>MIRU-VNTR 24 loci</title><p id="Par27">The MIRU-VNTR 24 loci was performed according to the protocol described by Supply et al. [<xref ref-type="bibr" rid="CR9">9</xref>] in 2006. This procedure used a monoplex PCR, using the fragments revealed by electrophoresis, in 2% agarose gel. In the construction of the dendogram, the Neighbor-Joining (NJ) algorithm was used to analyze the categorical data.</p></sec><sec id="Sec10"><title>Statistical analyses</title><p id="Par28">Associations were calculated using the chi-square and Fisher’s tests, and performed by STATA 12 software (Copyright 1985–2015 StataCorpLP©, USA).</p></sec><sec id="Sec11"><title>Phylogenetic analyses</title><p id="Par29">The analyses were performed using these free sites: the SITVIT website <ext-link xlink:href="http://www.pasteur-guadeloupe.fr:8081/SITVIT_ONLINE/" ext-link-type="url">http://www.pasteur-guadeloupe.fr:8081/SITVIT_ONLINE/</ext-link> and the MIRU-VNTRplus Server Policy <ext-link xlink:href="http://www.miru-vntrplus.org/MIRU/index.faces" ext-link-type="url">http://www.miru-vntrplus.org/MIRU/index.faces</ext-link>, as well as with Bionumerics 7.0©Applied Math software (Sint maertens, Latem, Belgium).</p></sec></sec><sec id="Sec12" sec-type="results"><title>Results</title><sec id="Sec13"><title><italic>Mycobacterium tuberculosis</italic> RD<sup>Rio</sup> - frequency and association with MDR-TB</title><p id="Par30">Among the 235 <italic>M. tuberculosis</italic> isolates, 122 (51.9%) were identified as RD<sup>Rio</sup> (IC 0.45–0.58), 100 (42.5%) as NO-RD<sup>Rio</sup>, and 13 (5.5%) as mixed pattern. The relationship between the RD<sup>Rio</sup> sublineage and MDR-TB was significant (<italic>p</italic> &lt; 0.001, chi-square test). The percentages of RD<sup>Rio</sup> and NO-RD<sup>Rio</sup> in susceptible and MDR-TB clinical isolates are shown in Fig. <xref rid="Fig1" ref-type="fig">1</xref>.<fig id="Fig1"><label>Fig. 1</label><caption xml:lang="en"><p><italic>Mycobacterium tuberculosis</italic> RD<sup>Rio</sup> and its association with MDR-TB. This grafics shows the percentages of RD<sup>Rio</sup> and NO-RD<sup>Rio</sup> in susceptible and MDR-TB clinical isolates. It’s important to highlight the relationship between the RD<sup>Rio</sup> sublineage and MDR-TB was significant (<italic>p</italic> &lt; 0.001)</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/12879_2019_4152_Fig1_HTML.png" id="MO1"/></p></fig></p><p id="Par31">Of the 122 <italic>M. tuberculosis</italic> RD<sup>Rio</sup>, 116 (95.1%) were identified as LAM, while the remaining six (4.9%) were identified as WT based on the Ag85C103 SNP, and this relationship was significant (<italic>p</italic> &lt; 0.000, chi-square test, and <italic>p</italic> &lt; 0.000, Fisher’s exact test). The genetic profiles of these six RD<sup>Rio</sup>, classified as WT by means of AG85C103 SNP, and found after analyses performed by spoligotyping and MIRU-VNTR 24 loci, are described in Table <xref rid="Tab1" ref-type="table">1</xref>.<table-wrap id="Tab1"><label>Table 1</label><caption xml:lang="en"><p>Genotypic profile of the <italic>Mycobacterium tuberculosis</italic> RD<sup>Rio</sup> isolates, classified as wild type through the SNP AG85</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="3"><p><italic>M. tuberculosis</italic> RD<sup>Rio</sup></p></th></tr><tr><th><p>Spoligotyping</p></th><th><p>MIRU-VNTR 24 loci</p></th><th><p>SNP AG85</p></th></tr></thead><tbody><tr><td><p>T1</p></td><td><p>Delhi/CAS</p></td><td><p>WT</p></td></tr><tr><td><p>T1</p></td><td><p>Haarlem</p></td><td><p>WT</p></td></tr><tr><td><p>H3</p></td><td><p>Haarlem</p></td><td><p>WT</p></td></tr><tr><td><p>LAM 1</p></td><td><p>Cameroon</p></td><td><p>WT</p></td></tr><tr><td><p>LAM 2</p></td><td><p>LAM</p></td><td><p>WT</p></td></tr><tr><td><p>Unknown</p></td><td><p>LAM</p></td><td><p>WT</p></td></tr></tbody></table><table-wrap-foot><p>Legend: *WT: Wild Type</p></table-wrap-foot></table-wrap></p><p id="Par32">The spoligotyping show that the majority of the RD<sup>Rio</sup> isolates proved to be LAM. The RD<sup>Rio</sup> spoligotyping’s patterns are shown in Fig. <xref rid="Fig2" ref-type="fig">2</xref>. The distribution of profiles found among drug resistant and susceptible isolates is shown in Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>. The spoligotyping classifications for all 172 sensitive and 63 MDR isolates are described in Table <xref rid="Tab2" ref-type="table">2</xref>.<fig id="Fig2"><label>Fig. 2</label><caption xml:lang="en"><p>The spoligotyping of <italic>M. tuberculosis</italic> RD<sup>Rio</sup>. A = The distribuition of RD<sup>Rio</sup> spoligotyping’s pattern of the LAM family. B = The distribuition of RD<sup>Rio</sup> spoligotyping’s pattern of the NO-LAM families</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/12879_2019_4152_Fig2_HTML.png" id="MO2"/></p></fig><table-wrap id="Tab2"><label>Table 2</label><caption xml:lang="en"><p>Classification of <italic>Mycobacterium tuberculosis</italic> strains in Minas Gerais according to spoligotyping</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th colspan="2"><p><italic>M. tuberculosis</italic></p></th></tr><tr><th><p>Lineages</p></th><th><p>Sensitive <sub><italic>n</italic> = 172</sub> (73%)</p></th><th><p>MDR <sub><italic>n</italic> = 63</sub> (27%)</p></th></tr></thead><tbody><tr><td><p>LAM 9</p></td><td><p>34 (19.7)</p></td><td><p>18 (28.5)</p></td></tr><tr><td><p>LAM 1</p></td><td><p>20 (11.6)</p></td><td><p>13 (20.6)</p></td></tr><tr><td><p>LAM 2</p></td><td><p>18 (10.5)</p></td><td><p>4 (6.3)</p></td></tr><tr><td><p>LAM 3</p></td><td><p>12 (6.9)</p></td><td><p>2 (3.7)</p></td></tr><tr><td><p>LAM 4</p></td><td><p>6 (3.5)</p></td><td><p>2 (3.7)</p></td></tr><tr><td><p>LAM 5</p></td><td><p>5 (2.9)</p></td><td><p>3 (4.7)</p></td></tr><tr><td><p>LAM 6</p></td><td><p>2 (1.2)</p></td><td><p>–</p></td></tr><tr><td><p>LAM 11-ZWE</p></td><td><p>4 (2.3)</p></td><td><p>–</p></td></tr><tr><td><p>T1</p></td><td><p>16 (9.3)</p></td><td><p>9 (14.2)</p></td></tr><tr><td><p>T2</p></td><td><p>2 (1.2)</p></td><td><p>2 (3.7)</p></td></tr><tr><td><p>T3</p></td><td><p>2 (1.2)</p></td><td><p>–</p></td></tr><tr><td><p>T4-CEU</p></td><td><p>2 (1.2)</p></td><td><p>–</p></td></tr><tr><td><p>T5-Madrid2</p></td><td><p>2 (1.2)</p></td><td><p>–</p></td></tr><tr><td><p>T3/T2</p></td><td><p>1 (1.6)</p></td><td><p>–</p></td></tr><tr><td><p>H1</p></td><td><p>4 (2.3)</p></td><td><p>1 (1.5)</p></td></tr><tr><td><p>H2</p></td><td><p>2 (1.2)</p></td><td><p>–</p></td></tr><tr><td><p>H3</p></td><td><p>10 (5.8)</p></td><td><p>1 (1.5)</p></td></tr><tr><td><p>Haarlem</p></td><td><p>2 (1.2)</p></td><td><p>–</p></td></tr><tr><td><p>X2</p></td><td><p>9 (5.2)</p></td><td><p>2 (3.7)</p></td></tr><tr><td><p>Orphan</p></td><td><p>4 (2.3)</p></td><td><p>–</p></td></tr><tr><td><p><italic>Unkonwn</italic></p></td><td><p>18 (10.5)</p></td><td><p>7 (11.1)</p></td></tr></tbody></table></table-wrap></p></sec><sec id="Sec14"><title>Identification of the RD174 pattern</title><p id="Par33">Among the 235 isolates of <italic>M. tuberculosis</italic>, the RD174 pattern was identified in 98 (41.7%), while 111 (47.2%) were WT and 26 (11.1%) presented a mixed pattern (RD174/WT).</p><p id="Par34">Of the 98 isolates that presented as RD174, 93/98 (94.9%) were identified as RD<sup>Rio</sup> (<italic>p</italic> &lt; 0.000, chi-square test).</p><p id="Par35">Among the 63 resistant <italic>M. tuberculosis</italic>, 28 (44.4%) presented the RD174 pattern, while among the 172 sensitive isolates 90 (52.3%) presented the WT pattern. The relationship between the RD174 pattern and TB drug resistance was significant, as was relationship between the WT pattern and drug sensitivity (<italic>p</italic> &lt; 0.001, chi-square test, and <italic>p</italic> &lt; 0.002, Fisher’s exact test).</p></sec><sec id="Sec15"><title>Identification of the Ag85C103 SNP and comparison with spoligotyping</title><p id="Par36">Of the 235 <italic>M. tuberculosis</italic> identified by the Ag85C103 SNP, 175 (74.4%) were classified as LAM, 54 (23%) as non-LAM, and six (2.5%) presented a mixed pattern (SNP/nonSNP). The profile of these isolates is described in Table <xref rid="Tab3" ref-type="table">3</xref>, of which only one presented a mixed pattern concurrent with the other markers (RD<sup>Rio</sup> and RD174). The relationship between these and the spoligotyping results is shown in Fig. <xref rid="Fig3" ref-type="fig">3</xref>.<table-wrap id="Tab3"><label>Table 3</label><caption xml:lang="en"><p>Genotypic profile of <italic>M. tuberculosis</italic> exhibiting a mixed pattern in AG85C103 SNP analysis</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="3"><p><italic>M. tuberculosis</italic> AG85C103 SNP mixed pattern</p></th></tr><tr><th><p>Spoligotyping</p></th><th><p>MIRU-VNTR 24 loci</p></th><th><p>RD<sup>Rio</sup></p></th></tr></thead><tbody><tr><td><p>T1</p></td><td><p>UgandaI</p></td><td><p>NO RD<sup>Rio</sup></p></td></tr><tr><td><p>T3</p></td><td><p>X</p></td><td><p>NO RD<sup>Rio</sup></p></td></tr><tr><td><p>LAM 9</p></td><td><p>Cameroon</p></td><td><p>Mixed</p></td></tr><tr><td><p>X2</p></td><td><p>X</p></td><td><p>NO RD<sup>Rio</sup></p></td></tr><tr><td><p>T5-Madrid2</p></td><td><p>Cameroon</p></td><td><p>NO RD<sup>Rio</sup></p></td></tr><tr><td><p>H3</p></td><td><p>Haarlem</p></td><td><p>NO RD<sup>Rio</sup></p></td></tr></tbody></table></table-wrap><fig id="Fig3"><label>Fig. 3</label><caption xml:lang="en"><p>The relationship between Ag85C103 SNP and spoligotyping. Purple circle – spoligotyping, Blue circle <bold>-</bold> Ag85C103</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/12879_2019_4152_Fig3_HTML.png" id="MO3"/></p></fig></p><p id="Par37">Analysis of the Ag85C103 SNP detected a higher frequency of LAM genotypes than spoligotyping, and this difference proved to be significant (<italic>p</italic> &lt; 0.000, chi-square test, and <italic>p</italic> &lt; 0.003, Fisher’s exact test).</p><p id="Par38">No significant difference was observed between susceptible and resistant <italic>M. tuberculosis</italic> in isolates characterized as LAM by Ag85C103 (<italic>p</italic> &lt; 0.309, chi-square test, and <italic>p</italic> &lt; 0.428, Fisher’s exact test).</p></sec><sec id="Sec16"><title>MIRU-VNTR 24 loci</title><p id="Par39">Among the 235 isolates, MIRU-VNTR 24 loci typing revealed the following families: LAM, 136 (69.4%); Haarlem, 36 (15.3%); Cameroon, 13 (5.5%); X, 10 (4.3%); Unganda I, 7 (3%); Delhi/CAS, 4 (1.7%); one from Ghana (0.4%), and one from a NEW-1 type. A UPGMA-based dendrogram demonstrates the four clusters of the RD<sup>Rio</sup> sublineage (Figs. <xref rid="Fig4" ref-type="fig">4</xref> and <xref rid="Fig5" ref-type="fig">5</xref>).<fig id="Fig4"><label>Fig. 4</label><caption xml:lang="en"><p>Dendogram of association by MIRU-VNTR 24 loci, spoligotyping, and RD174. A = Dendogram with association of all strains with the pattern RD174 and this respective MIRU-VNTR 24 loci. B = The spoligotyping of all strains with the pattern RD174</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/12879_2019_4152_Fig4_HTML.png" id="MO4"/></p></fig><fig id="Fig5"><label>Fig. 5</label><caption xml:lang="en"><p>Dendogram of association by MIRU-VNTR 24 loci, spoligotyping, and RD<sup>Rio</sup>. A = Dendogram with association of all strains with the pattern RD<sup>Rio</sup> and this respective MIRU-VNTR 24 loci. B = The spoligotyping of all strains with the pattern RD<sup>Rio</sup></p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/12879_2019_4152_Fig5_HTML.png" id="MO5"/></p></fig></p></sec></sec><sec id="Sec17" sec-type="discussion"><title>Discussion</title><p id="Par40">The present study demonstrates a significant relationship between the RD<sup>Rio</sup> sublineage and MDR-TB, and is the first study of its kind in the state of Minas Gerais. In contrast to previous studies that only evaluated the frequency of this sublineage, it is important to note in the present study that we also evaluated the relationship of not only RD<sup>Rio</sup>, but also of other phylogenetic markers (RD174, Ag85C103 SNP), with their susceptibility or resistance to anti-TB drugs.</p><p id="Par41">Lazzarini et al. [<xref ref-type="bibr" rid="CR6">6</xref>] in 2007 suggested that the <italic>M. tuberculosis</italic> genotype RD<sup>Rio</sup> originated from a common progenitor, since IS1561 deletion was also found in other countries. In addition, besides their capacity for progressive primary TB, isolates with this genotype have been associated with the development of the MDR phenotype [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>].</p><p id="Par42">The high frequency of RD<sup>Rio</sup> observed in this study population may well be due to the predominance of the LAM family and the LAM9 lineage, since they are the most common progenitors of this sublineage [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. We also observed a statistically significant predominance of the RD<sup>Rio</sup> sublineage among MDR isolates, as compared to sensitive isolates. This result is consistent with data obtained in Porto Alegre, where RD<sup>Rio</sup> was observed in 56 of the 115 MDR isolates, accounting for almost half of the resistant isolate cases [<xref ref-type="bibr" rid="CR12">12</xref>]. In a study performed in Portugal, the RD<sup>Rio</sup> frequency was 60% among MDR isolates [<xref ref-type="bibr" rid="CR3">3</xref>], while in the United States and Spain the RD<sup>Rio</sup> frequency in MDR isolates was no higher than in sensitive isolates, but was identified among both MDR and isoniazid monoresistant isolates [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. In those same studies in Spain and the United States, RD<sup>Rio</sup> was found in a higher proportion in Hispanic patients [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. Lazzarini et al. [<xref ref-type="bibr" rid="CR19">19</xref>] analyzed isolates from several parts of Brazil in 2008, and suggested that the sublineage RD<sup>Rio</sup> LAM could cause more severe disease (cavitary lung lesions), and most likely contributes to the transmission of TB among certain ethnic populations [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR19">19</xref>].</p><p id="Par43">RD<sup>Rio</sup> may have some biological advantage over other genotypes due to the deletion of two PPE genes (PPE55 and PPE56), and may minimize the host’s immunological recognition leading to increased virulence and/or transmissibility [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR12">12</xref>].</p><p id="Par44">In a study that evaluated RD<sup>Rio</sup> in TB contacts in Gambia [<xref ref-type="bibr" rid="CR20">20</xref>], RD174 was the second most frequent marker found, suggesting a certain association with the RD<sup>Rio</sup> deletion. The most frequent marker was RD702, but this was related to the transmission of <italic>M. africanum</italic> [<xref ref-type="bibr" rid="CR20">20</xref>].</p><p id="Par45">In our study, although RD174 was identified in most of the isolates with RD<sup>Rio</sup> (94.9%), and though the relationship between these markers was significant (<italic>p</italic> = 0.000), their correlation is not absolute. Therefore, when analyzing only RD174, one can overestimate the RD<sup>Rio</sup> frequency in the present population, as described by another author that analyzed isolates from Rio de Janeiro [<xref ref-type="bibr" rid="CR7">7</xref>]. This data contradicts a study by Gibson et al. [<xref ref-type="bibr" rid="CR4">4</xref>] in 2008, who considered RD174 an absolute marker for RD<sup>Rio</sup>. One explanation for this difference may well be the local features of sample selection.</p><p id="Par46">As shown in this work, spoligotyping exhibits limitations in differentiating Euro American families in populations that predominate with the LAM, H, and T families, and the fact that we found six RD<sup>Rio</sup> isolates characterized as Non-LAM by spoligotyping may be due to these limitation [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. The difficulty in differentiating these families comes from the large number of IS6110 of these strains produce, with many variations in the “Direct Repeat” (DR) locus, which gives rise to several profiles not identified by this technique (<italic>Unkonwn pattern</italic>), or with a high degree of homoplasy between the spacers that define different families [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. In this context, the Ag85C103 SNP is particularly important as a specific additional marker used to identify the frequency of the LAM family in a population [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par47">One limitation of this study is that since the RD<sup>Rio</sup> sublineage could not be correlated with patients’ clinical data, it was impossible to associate RD<sup>Rio</sup> strains with a prognosis for severe forms of TB. Another limitation is that we did not perform an entire genome analysis of the present strain’s population, and it has been shown that differences occur between this level of genotyping and 24 MIRU-VNTR typing and lineage definition. This finding would be particularly interesting for better characterizing the isolates that present with either RD<sup>Rio</sup> or RD174, but not both. However, we must emphasize that the methods employed in this study are feasibly useful in places with few resources. In contrast, though WGS reduces the processing time, it is still an expensive technology that demands heavy bioinformatics to analyze the data. The results of this study were obtained through simple molecular biology techniques and may be important for the control and monitoring of TB and TBMDR.</p></sec><sec id="Sec18" sec-type="conclusions"><title>Conclusions</title><p id="Par48">In conclusion, most of the isolates of <italic>M. tuberculosis</italic> in Minas Gerais belong to the LAM family, the LAM9 lineage, and the RD<sup>Rio</sup> sublineage. Both <italic>M. tuberculosis</italic> RD<sup>Rio</sup> and RD174 isolates positively correlated with MDR-TB. Because Brazil has a vast territory with considerable demographic and economic differences, further studies of RD<sup>Rio</sup> in other regions are required<italic>.</italic></p></sec></body><back><ack><title>Acknowledgments</title><p>The Research Support Foundation of Minas Gerais (FAPEMIG) (APQ 03266-13/APQ 00094-12) and the National Research Council (CNPq 446796/2014 and 310174/2017-7). The Postgraduate Program in Tropical Medicine and Infectology of the UFMG School of Medicine. The Ezequiel Dias Foundation (FUNED). The Oswaldo Cruz Foundation (Fiocruz) and the Brazilian Tuberculosis Research Network – REDE TB.</p></ack><sec sec-type="author-contribution"><title>Authors’ contributions</title><p>SSM, PNS and WSC designed the study. INA, LJAF, NGTD, CJA performed the experiments. JPAH provided the statistical analysis. INA, SEGV and PNS were responsible genomic analysis. INA, SEGV and LJAF drafted the initial manuscript. PNS, WSC, SSM revised the manuscript, and all authors approved the final content of this manuscript.</p></sec><sec><title>Funding</title><p>Funding was provided by The Research Support Foundation of Minas Gerais (FAPEMIG) (APQ 03266–13/APQ 00094–12) and the National Research Council (CNPq 446796/2014 and 310174/2017–7), as well as The Postgraduate Program in Tropical Medicine and Infectology of the UFMG School of Medicine and The Oswaldo Cruz Foundation (Fiocruz).</p></sec><sec sec-type="data-availability"><title>Availability of data and materials</title><p>The analyses for objectives of this study were conducted using STATA 12 software (Copyright 1985–2015 StataCorpLP©, USA). The data that support the findings of this study are available from Silvana Spindola de Miranda upon reasonable request by qualified researchers.</p></sec><sec sec-type="ethics-statement"><sec id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par49">This study was approved by the UFMG Research Ethics Committee (CAAE – 06611912.8.0000.5149). The consent to participate requirement was waived by the ethics committee, since clinical, sociodemographic and epidemiological data from patients were not included, and the studies were performed using DNA from culture and not extracted from clinical samples.</p></sec><sec id="FPar2"><title>Consent for publication</title><p id="Par50">Not applicable.</p></sec><sec id="FPar3" sec-type="COI-statement"><title>Competing interests</title><p id="Par51">The authors declare that they have no competing interests.</p></sec></sec><ref-list id="Bib1"><title>References</title><ref-list><ref id="CR1"><label>1.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><source>Global tuberculosis report 2018</source><year>2018</year><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weisenberg</surname><given-names>SA</given-names></name><name><surname>Gibson</surname><given-names>AL</given-names></name><name><surname>Huard</surname><given-names>RC</given-names></name><name><surname>Kurepina</surname><given-names>N</given-names></name><name><surname>Bang</surname><given-names>H</given-names></name><name><surname>Lazzarini</surname><given-names>LC</given-names></name><etal/></person-group><article-title xml:lang="en">Distinct clinical and epidemiological features of tuberculosis in new York City caused by the RDRio mycobacterium tuberculosis sublineage</article-title><source>Infect Genet Evol</source><year>2014</year><volume>27</volume><fpage>380</fpage><lpage>392</lpage></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>David</surname><given-names>S</given-names></name><name><surname>Duarte</surname><given-names>EL</given-names></name><name><surname>Leite</surname><given-names>CQF</given-names></name><name><surname>Ribeiro</surname><given-names>JN</given-names></name><name><surname>Maio</surname><given-names>JN</given-names></name><name><surname>Paixão</surname><given-names>E</given-names></name><etal/></person-group><article-title xml:lang="en">Implication of the RDRio mycobacterium tuberculosis sublineage in multidrug resistant tuberculosis in Portugal</article-title><source>Infect Genet Evol</source><year>2012</year><volume>12</volume><fpage>1362</fpage><lpage>1367</lpage><pub-id pub-id-type="doi">10.1016/j.meegid.2012.04.021</pub-id><pub-id pub-id-type="pmid">22569099</pub-id></mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibson</surname><given-names>AL</given-names></name><name><surname>Huard</surname><given-names>RC</given-names></name><name><surname>Gey Van Pittius</surname><given-names>NC</given-names></name><name><surname>Lazzarini</surname><given-names>LCO</given-names></name><name><surname>Driscoll</surname><given-names>J</given-names></name><name><surname>Kurepina</surname><given-names>N</given-names></name><etal/></person-group><article-title xml:lang="en">Application of sensitive and specific molecular methods to uncover global dissemination of the major RDRio sublineage of the Latin American-Mediterranean mycobacterium tuberculosis spoligotype family</article-title><source>J Clin Microbiol</source><year>2008</year><volume>46</volume><fpage>1259</fpage><lpage>1267</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXltFaqu7g%3D</pub-id><pub-id pub-id-type="doi">10.1128/JCM.02231-07</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynaud</surname><given-names>Y</given-names></name><name><surname>Millet</surname><given-names>J</given-names></name><name><surname>Rastogi</surname><given-names>N</given-names></name></person-group><article-title xml:lang="en">Genetic structuration, demography and evolutionary history of mycobacterium tuberculosis LAM9 sublineage in the Americas as two distinct subpopulations revealed by Bayesian analyses</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><fpage>1</fpage><lpage>15</lpage></mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazzarini</surname><given-names>LCO</given-names></name><name><surname>Huard</surname><given-names>RC</given-names></name><name><surname>Boechat</surname><given-names>NL</given-names></name><name><surname>Gomes</surname><given-names>HM</given-names></name><name><surname>Oelemann</surname><given-names>MC</given-names></name><name><surname>Kurepina</surname><given-names>N</given-names></name><etal/></person-group><article-title xml:lang="en">Discovery of a novel mycobacterium tuberculosis lineage that is a major cause of tuberculosis in Rio de Janeiro, Brazil</article-title><source>J Clin Microbiol</source><year>2007</year><volume>45</volume><fpage>3891</fpage><lpage>3902</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXntlWnsA%3D%3D</pub-id><pub-id pub-id-type="doi">10.1128/JCM.01394-07</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasconcellos</surname><given-names>Sidra E. G.</given-names></name><name><surname>Acosta</surname><given-names>Chyntia Carolina</given-names></name><name><surname>Gomes</surname><given-names>Lia Lima</given-names></name><name><surname>Conceição</surname><given-names>Emilyn Costa</given-names></name><name><surname>Lima</surname><given-names>Karla Valéria</given-names></name><name><surname>de Araujo</surname><given-names>Marcelo Ivens</given-names></name><name><surname>Leite</surname><given-names>Maria de Lourdes</given-names></name><name><surname>Tannure</surname><given-names>Flávio</given-names></name><name><surname>Caldas</surname><given-names>Paulo Cesar de Souza</given-names></name><name><surname>Gomes</surname><given-names>Harrison M.</given-names></name><name><surname>Santos</surname><given-names>Adalberto Rezende</given-names></name><name><surname>Gomgnimbou</surname><given-names>Michel K.</given-names></name><name><surname>Sola</surname><given-names>Christophe</given-names></name><name><surname>Couvin</surname><given-names>David</given-names></name><name><surname>Rastogi</surname><given-names>Nalin</given-names></name><name><surname>Boechat</surname><given-names>Neio</given-names></name><name><surname>Suffys</surname><given-names>Philip Noel</given-names></name></person-group><article-title xml:lang="en">Strain Classification of Mycobacterium tuberculosis Isolates in Brazil Based on Genotypes Obtained by Spoligotyping, Mycobacterial Interspersed Repetitive Unit Typing and the Presence of Large Sequence and Single Nucleotide Polymorphism</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><issue>10</issue><fpage>e107747</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0107747</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>HM</given-names></name><name><surname>Elias</surname><given-names>AR</given-names></name><name><surname>Oelemann</surname><given-names>MAC</given-names></name><name><surname>Pereira</surname><given-names>MA d S</given-names></name><name><surname>Montes</surname><given-names>FFO</given-names></name><name><surname>Marsico</surname><given-names>AG</given-names></name><etal/></person-group><article-title xml:lang="en">Spoligotypes of mycobacterium tuberculosis complex isolates from patients residents of 11 states of Brazil</article-title><source>Infect Genet Evol</source><year>2012</year><volume>12</volume><fpage>649</fpage><lpage>656</lpage><pub-id pub-id-type="doi">10.1016/j.meegid.2011.08.027</pub-id><pub-id pub-id-type="pmid">21907830</pub-id></mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Supply</surname><given-names>P</given-names></name><name><surname>Allix</surname><given-names>C</given-names></name><name><surname>Lesjean</surname><given-names>S</given-names></name><name><surname>Cardoso-Oelemann</surname><given-names>M</given-names></name><name><surname>Rüsch-Gerdes</surname><given-names>S</given-names></name><name><surname>Willery</surname><given-names>E</given-names></name><etal/></person-group><article-title xml:lang="en">Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of mycobacterium tuberculosis</article-title><source>J Clin Microbiol</source><year>2006</year><volume>44</volume><fpage>4498</fpage><lpage>4510</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXmslKjsQ%3D%3D</pub-id><pub-id pub-id-type="doi">10.1128/JCM.01392-06</pub-id></mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardoso Oelemann</surname><given-names>Maranibia</given-names></name><name><surname>Gomes</surname><given-names>Harrison M.</given-names></name><name><surname>Willery</surname><given-names>Eve</given-names></name><name><surname>Possuelo</surname><given-names>Lia</given-names></name><name><surname>Batista Lima</surname><given-names>Karla Valéria</given-names></name><name><surname>Allix-Béguec</surname><given-names>Caroline</given-names></name><name><surname>Locht</surname><given-names>Camille</given-names></name><name><surname>Goguet de la Salmonière</surname><given-names>Yves-Olivier L.</given-names></name><name><surname>Gutierrez</surname><given-names>Maria Cristina</given-names></name><name><surname>Suffys</surname><given-names>Philip</given-names></name><name><surname>Supply</surname><given-names>Philip</given-names></name></person-group><article-title xml:lang="en">The Forest behind the Tree: Phylogenetic Exploration of a Dominant Mycobacterium tuberculosis Strain Lineage from a High Tuberculosis Burden Country</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><issue>3</issue><fpage>e18256</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0018256</pub-id></mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Augusto</surname><given-names>Cláudio José</given-names></name><name><surname>Carvalho</surname><given-names>Wânia da Silva</given-names></name><name><surname>Almeida</surname><given-names>Isabela Neves de</given-names></name><name><surname>Figueiredo</surname><given-names>Lida Jouca de Assis</given-names></name><name><surname>Dantas</surname><given-names>Nayanne Gama Teixeira</given-names></name><name><surname>Suffys</surname><given-names>Philip Noel</given-names></name><name><surname>Miranda</surname><given-names>Silvana Spíndola de</given-names></name></person-group><article-title xml:lang="en">Comparative study of RFLP-IS6110 and MIRU-VNTR from  Mycobacterium tuberculosis  isolated in the state of Minas Gerais, Brazil</article-title><source>Brazilian Journal of Microbiology</source><year>2018</year><volume>49</volume><issue>3</issue><fpage>641</fpage><lpage>646</lpage><pub-id pub-id-type="doi">10.1016/j.bjm.2017.04.015</pub-id></mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalla Costa</surname><given-names>Elis R</given-names></name><name><surname>Ribeiro</surname><given-names>Marta O</given-names></name><name><surname>Silva</surname><given-names>Márcia SN</given-names></name><name><surname>Arnold</surname><given-names>Liane S</given-names></name><name><surname>Rostirolla</surname><given-names>Diana C</given-names></name><name><surname>Cafrune</surname><given-names>Patricia I</given-names></name><name><surname>Espinoza</surname><given-names>Roger C</given-names></name><name><surname>Palaci</surname><given-names>Moises</given-names></name><name><surname>Telles</surname><given-names>Maria A</given-names></name><name><surname>Ritacco</surname><given-names>Viviana</given-names></name><name><surname>Suffys</surname><given-names>Philip N</given-names></name><name><surname>Lopes</surname><given-names>Maria L</given-names></name><name><surname>Campelo</surname><given-names>Creuza L</given-names></name><name><surname>Miranda</surname><given-names>Silvana S</given-names></name><name><surname>Kremer</surname><given-names>Kristin</given-names></name><name><surname>da Silva</surname><given-names>Pedro</given-names></name><name><surname>Fonseca</surname><given-names>Leila</given-names></name><name><surname>Ho</surname><given-names>John L</given-names></name><name><surname>Kritski</surname><given-names>Afrânio L</given-names></name><name><surname>Rossetti</surname><given-names>Maria LR</given-names></name></person-group><article-title xml:lang="en">Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America</article-title><source>BMC Microbiology</source><year>2009</year><volume>9</volume><issue>1</issue><fpage>39</fpage><pub-id pub-id-type="doi">10.1186/1471-2180-9-39</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="other">Augusto CJ, Carvalho WS, Gonçalves AD, Ceccato MGB, de Miranda SS. Characteristics of tuberculosis in the state of Minas Gerais, Brazil: 2002-2009. J Bras Pneumol. 2013;39.</mixed-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="other">BRASIL. Manual nacional de vigilância laboratorial da tuberculose e outras micobactérias. Secretaria de Vigilância em Saúde, Departamento de Vigilância Epidemiológica - Ministério da Saúde 2011.</mixed-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="other">Siddiqi SH, Rüsch-Gerdes S. For BACTEC™ MGIT 960™ TB System (Also applicable for Manual MGIT) 2006; July.</mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="other">Dantas NGT, Suffys PN, Carvalho WS, Gomes HM, de Almeida IN, de Assis LJ, et al. Genetic diversity and molecular epidemiology of multidrug-resistant mycobacterium tuberculosis in Minas Gerais state, Brazil. BMC Infect Dis. 2015;15.</mixed-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Abadia</surname><given-names>E</given-names></name><name><surname>Refregier</surname><given-names>G</given-names></name><name><surname>Tafaj</surname><given-names>S</given-names></name><name><surname>Boschiroli</surname><given-names>ML</given-names></name><name><surname>Guillard</surname><given-names>B</given-names></name><etal/></person-group><article-title xml:lang="en">Mycobacterium tuberculosis complex CRISPR genotyping: improving efficiency, throughput and discriminative power of “spoligotyping” with new spacers and a microbead-based hybridization assay</article-title><source>J Med Microbiol</source><year>2010</year><volume>59</volume><fpage>285</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1099/jmm.0.016949-0</pub-id></mixed-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ippolito</surname><given-names>G</given-names></name><name><surname>Nisii</surname><given-names>C</given-names></name><name><surname>Di Caro</surname><given-names>A</given-names></name><name><surname>Brown</surname><given-names>D</given-names></name><name><surname>Gopal</surname><given-names>R</given-names></name><name><surname>Hewson</surname><given-names>R</given-names></name><etal/></person-group><article-title xml:lang="en">European perspective of 2-person rule for biosafety level 4 laboratories</article-title><source>Emerg Infect Dis</source><year>2009</year><volume>15</volume><fpage>1858a</fpage><lpage>11860</lpage><pub-id pub-id-type="doi">10.3201/eid1511.091134</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazzarini</surname><given-names>LCO</given-names></name><name><surname>Spindola</surname><given-names>SM</given-names></name><name><surname>Bang</surname><given-names>H</given-names></name><name><surname>Gibson</surname><given-names>AL</given-names></name><name><surname>Weisenberg</surname><given-names>S</given-names></name><name><surname>Carvalho</surname><given-names>WDS</given-names></name><etal/></person-group><article-title xml:lang="en">RDRio mycobacterium tuberculosis infection is associated with a higher frequency of cavitary pulmonary disease</article-title><source>J Clin Microbiol</source><year>2008</year><volume>46</volume><fpage>2175</fpage><lpage>2183</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXps1Onu78%3D</pub-id><pub-id pub-id-type="doi">10.1128/JCM.00065-08</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Jong</surname><given-names>BC</given-names></name><name><surname>Antonio</surname><given-names>M</given-names></name><name><surname>Awine</surname><given-names>T</given-names></name><name><surname>Ogungbemi</surname><given-names>K</given-names></name><name><surname>De Jong</surname><given-names>YP</given-names></name><name><surname>Gagneux</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">Use of spoligotyping and large sequence polymorphisms to study the population structure of the mycobacterium tuberculosis complex in a cohort study of consecutive smear-positive tuberculosis cases in the Gambia∇</article-title><source>J Clin Microbiol</source><year>2009</year><volume>47</volume><fpage>994</fpage><lpage>1001</lpage><pub-id pub-id-type="doi">10.1128/JCM.01216-08</pub-id></mixed-citation></ref></ref-list></ref-list><app-group><app id="App1"><sec id="Sec19"><title>Additional file</title><p id="Par52"><supplementary-material content-type="local-data" id="MOESM1" xlink:title="Additional file"><media xlink:href="MediaObjects/12879_2019_4152_MOESM1_ESM.docx" mimetype="application" mime-subtype="msword"><caption xml:lang="en"><p>The Genetic profile of <italic>Mycobacterium tuberculosis</italic> RD<sup>Rio</sup> in Minas Gerais as defined by spoligotyping (DOCX 23 kb)</p></caption></media></supplementary-material></p></sec></app></app-group><glossary><title>Abbreviations</title><def-list><def-item><term>LAM</term><def><p id="Par5">Latin American – Mediterranean</p></def></def-item><def-item><term><italic>M. tuberculosis</italic></term><def><p id="Par6"><italic>Mycobacterium tuberculosis</italic></p></def></def-item><def-item><term>MDR-TB</term><def><p id="Par7">Multidrug-resistant tuberculosis</p></def></def-item><def-item><term>MIRU-VNTR</term><def><p id="Par8">Variable Number Tandem Repeat – Mycobaterial Interspersed Repetitive Unit</p></def></def-item><def-item><term>PPE</term><def><p id="Par9">Proline-glutamic Acid Proteins</p></def></def-item><def-item><term>RR-TB</term><def><p id="Par10">Rifampicin-resistant tuberculosis</p></def></def-item><def-item><term>SNP</term><def><p id="Par11">Single Nucleotide Polymorphism</p></def></def-item><def-item><term>TB</term><def><p id="Par12">Tuberculosis</p></def></def-item><def-item><term>WT</term><def><p id="Par13">Wild-type</p></def></def-item></def-list></glossary><notes notes-type="Misc"><title>Publisher’s Note</title><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></notes></back></article></records><facets><facet name="subject"><facet-value count="1">Infectious Diseases</facet-value><facet-value count="1">Internal Medicine</facet-value><facet-value count="1">Medical Microbiology</facet-value><facet-value count="1">Medicine &amp; Public Health</facet-value><facet-value count="1">Parasitology</facet-value><facet-value count="1">Tropical Medicine</facet-value></facet><facet name="keyword"><facet-value count="1">
                Mycobacterium tuberculosis
              </facet-value><facet-value count="1">Genotype</facet-value><facet-value count="1">Multidrug-resistant tuberculosis</facet-value><facet-value count="1">Single nucleotide polymorphisms</facet-value><facet-value count="1">Tuberculosis</facet-value></facet><facet name="pub"><facet-value count="1">BMC Infectious Diseases</facet-value></facet><facet name="year"><facet-value count="1">2019</facet-value></facet><facet name="country"><facet-value count="1">Brazil</facet-value></facet><facet name="type"><facet-value count="1">Journal</facet-value></facet></facets></response>
